SCHEMBL1970099

SCHEMBL1970099

[CH2]C(C)(C)CC(C)CCC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28113042 0.86 TSHR (0.36) TSHR
SCHEMBL1974644 0.85 DNM1 (0.33)
SCHEMBL1973742 0.83 OPRM1 (0.41)
SCHEMBL28862050 0.81 ACE2 (0.42) TSHR
SCHEMBL7537993 0.81 ACE2 (0.42) TSHR
SCHEMBL28049474 0.80 TSHR (0.39) TSHR
SCHEMBL17607446 0.79 MEN1 (0.32)
SCHEMBL20957486 0.79 TSHR (0.42) TSHR
SCHEMBL597865 0.78 TSHR (0.46) TSHR
SCHEMBL1969594 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116730979-A Pol theta inhibitor 武汉人福创新药物研发中心有限公司 2023-09-12 CN disclosed
US-11345680-B2 Method for producing bispyrrolidine compounds BASF SE (DE) 2022-05-31 US disclosed
US-20200392115-A1 METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS BASF SE (DE) 2020-12-17 US disclosed
EP-3713915-A1 METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS BASF SE (DE) 2020-09-30 EP disclosed
CN-111372916-A Process for producing bispyrrolidine compounds 巴斯夫欧洲公司 2020-07-03 CN disclosed
WO-2019101568-A1 METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS BASF SE (DE) 2019-05-31 WO disclosed
CN-105969543-B Flue dust cleaning agent after fire 江苏筑磊电子科技有限公司 2019-04-05 CN disclosed
US-9469662-B2 Process for preparing optically active biophosphinylalkanes BASF SE (DE) 2016-10-18 US disclosed
CN-105969543-A Smoke dust cleaning agent after fire hazards 江苏筑磊电子科技有限公司 2016-09-28 CN disclosed
EP-1913007-B1 PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES BASF SE (DE) 2011-06-22 EP disclosed
US-20080242893-A1 Process for Preparing Optically Active Diphosphanes BASF AKTIENGESELLSCHAFT (DE) 2008-10-02 US disclosed
EP-0151282-B1 OPTICALLY ACTIVE 3,4-BIS-(DIPHENYLPHOSPHINO)-PYRROLIDINE, RHODIUM COMPLEXES CONTAINING THEM AS CHIRAL LIGANDS, AND THEIR USE Degussa Aktiengesellschaft (DE) 1988-09-07 EP disclosed
EP-0151282-A1 Optically active 3,4-bis-(diphenylphosphino)-pyrrolidine, rhodium complexes containing them as chiral ligands, and their use Degussa Aktiengesellschaft (DE) 1985-08-14 EP disclosed
US-4083849-A Process for preparation of 5-cyanopyrid-6-ones BASF AKTIENGESELLSCHAFT (DT) 1978-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392115-A1 METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS BBOX1, DHPS, BCKDK TSHR 4272/4885
US-11345680-B2 Method for producing bispyrrolidine compounds BCKDK, BBOX1, DHPS TSHR 4288/4885
US-20080242893-A1 Process for Preparing Optically Active Diphosphanes PHOSPHO1, DCTPP1, DCPS TSHR 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.